Wednesday, November 26, 2025 | 10:05 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

Sputnik V, Dr Reddy’s Laboratories, DRL, coronavirus, vaccine, covid-19
premium

DRL has lined up over 250 million doses of the vaccine for Indian citizens over next 12 months

Sohini Das Mumbai
India may soon have a third Covid-19 vaccine in the next few weeks with emergency use authorisation for the Russian jab Sputnik V.

“We expect to get the approval in the next few weeks,” said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL).

DRL had applied for restricted emergency use authorisation for Sputnik V in February. It has already lined up over 250 million doses of the vaccine for Indian citizens (from manufacturing partners) over the next 12 months.

The Russian Direct Investment Fund (RDIF) has formed manufacturing tie-ups with several partners in India to make around 752 million doses